Drawing for NEOLAB

USPTO serial 86983972

NEOLAB

Reviewed by CopyMark Law Group

Reg. 5541474Status 705Registered
Filing date
Status date
Registration date
Aug 14, 2018
Examiner
SAKAI, ADA HAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with NEOLAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anessa O. Kramer

Anessa O. Kramer Honigman LLP39400 Woodward Avenue, Suite 101Bloomfield Hills, MI 48304-5151United States

Goods and services

ClassDescriptionStatusFirst use
001[ Pre-packaged medical tests kits and medical test kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of DNA probes and also containing clinical medical reagents and antibodies for use in disease testing for clinical medical laboratory use]SECTION 8 - CANCELLEDSep 5, 2014
005Medical tests kits primarily comprised of medical diagnostic reagents and assays for testing body fluidsACTIVESep 5, 2014
042Scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory services, oncology reference laboratory services, providing information, interactive information, and reports, to others in the field of pathology, diagnostic testing, oncology testingACTIVESep 5, 2014
044Medical diagnostic testing services in the field of human disease and human medical conditionsACTIVESep 5, 2014

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 6, 2024C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 6, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 16, 2024E815TEAS SECTION 8 & 15 RECEIVED
Aug 14, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 1, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 1, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 1, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 1, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 10, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 10, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 10, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 10, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 13, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 13, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 13, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 3, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 14, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 10, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 9, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 29, 2018DPCCDIVISIONAL PROCESSING COMPLETE
Jun 6, 2018DRRRDIVISIONAL REQUEST RECEIVED
Jun 6, 2018ERTDTEAS REQUEST TO DIVIDE RECEIVED
Mar 8, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2018CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 1, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 8, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 8, 2017CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 4, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE
Jun 15, 2017IUAFUSE AMENDMENT FILED
Jun 15, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 11, 2017ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 14, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 13, 2016EX4GSOU EXTENSION 4 GRANTED
Dec 7, 2016EXT4SOU EXTENSION 4 FILED
Dec 7, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 9, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 8, 2016EX3GSOU EXTENSION 3 GRANTED
May 31, 2016EXT3SOU EXTENSION 3 FILED
May 31, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 5, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 4, 2016EX2GSOU EXTENSION 2 GRANTED
Dec 15, 2015EXT2SOU EXTENSION 2 FILED
Dec 15, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 9, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2015EX1GSOU EXTENSION 1 GRANTED
Jul 8, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 9, 2015EXT1SOU EXTENSION 1 FILED
Jun 9, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 16, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 21, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 1, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 15, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 10, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2014ALIEASSIGNED TO LIE
Aug 21, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 14, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 13, 2014DOCKASSIGNED TO EXAMINER
Jul 12, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED
Jul 11, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2014NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance